HIGHLIGHTS
- who: Vasudha Tandon from the Vasudha Tandon, Laureano de la Vega, and Sourav Banerjee* From the Division of Cellular Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom Edited by Alex Toker have published the paper: Emerging roles of DYRK2 in cancer, in the Journal: (JOURNAL) of September/23,/2020
- what: The study showed that DYRK2 depletion either by si/shRNA or CRISPR/ Cas9 KO led to a 30 to 40% decrease in proteasome activity .
SUMMARY
Indeed, potent and selective small-molecule inhibitors of DYRK2 exhibit in_vitro and in_vivo anti . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.